These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12727815)
1. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815 [TBL] [Abstract][Full Text] [Related]
2. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901 [TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335 [TBL] [Abstract][Full Text] [Related]
4. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585 [TBL] [Abstract][Full Text] [Related]
5. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer. Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Chen J; Amos CI; Merriman KW; Wei Q; Sen S; Killary AM; Frazier ML Pancreas; 2010 Jan; 39(1):1-4. PubMed ID: 19910837 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study. Liu F; Wei YG; Luo LM; Wang WT; Yan LN; Wen TF; Xu MQ; Yang JY; Li B Int J Cancer; 2013 May; 132(9):2056-64. PubMed ID: 23034899 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma. Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272 [TBL] [Abstract][Full Text] [Related]
9. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage. Xu J; Langefeld CD; Zheng SL; Gillanders EM; Chang BL; Isaacs SD; Williams AH; Wiley KE; Dimitrov L; Meyers DA; Walsh PC; Trent JM; Isaacs WB Hum Genet; 2004 Aug; 115(3):255-62. PubMed ID: 15185141 [TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916 [TBL] [Abstract][Full Text] [Related]
12. CDKN1A (p21 gene) polymorphisms correlates with age in esophageal cancer. Kaya Z; Karan BM; Almalı N Mol Biol Rep; 2022 Jan; 49(1):249-258. PubMed ID: 34743275 [TBL] [Abstract][Full Text] [Related]
13. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776 [TBL] [Abstract][Full Text] [Related]
14. Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis. Xiang H; Li H; Ge W; Wu W; Gao M; Wang W; Hong L; Jiang D; Zhang C Mol Biol Rep; 2013 Nov; 40(11):6371-7. PubMed ID: 24078094 [TBL] [Abstract][Full Text] [Related]
15. Association between CDKN1A gene rs1801270 polymorphisms and susceptibility to colorectal cancser in an Iranian population. Zali N; Savabkar S; Tajali R; Chaleshi V; Nazemalhosseini Mojarad E; Vahedi M; Hashemi M; Asadzadeh Aghdaei H Nucleosides Nucleotides Nucleic Acids; 2023; 42(7):563-570. PubMed ID: 36691945 [No Abstract] [Full Text] [Related]
16. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701 [TBL] [Abstract][Full Text] [Related]
17. Contribution of Cyclin-dependent Kinase Inhibitor 1B Genotypes to Childhood Leukemia Risk. Pei JS; Chang WS; Hsu PC; Chen CC; Yang YC; Hsu SW; Hsu YN; Wang YC; Wang CH; Tsai CW; Bau DT In Vivo; 2022; 36(4):1637-1642. PubMed ID: 35738638 [TBL] [Abstract][Full Text] [Related]
18. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility. Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402 [TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
20. Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis. Cacina C; Yaylim-Eraltan I; Arikan S; Saglam EK; Zeybek U; Isbir T In Vivo; 2010; 24(2):179-83. PubMed ID: 20363991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]